AzTrials
AzTrials

Mobility LimitationMATNCT03032341

Mobility Assessment Using Surrogates in Elderly Participants

An observational study of Mobility Limitation, run by Wake Forest University Health Sciences at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research study is to find out if mobility (the ability to move around) can be reliably assessed by having the family or care giver caregiver take a video based test for the patient. Read more about this study

Who is it for?
Ages 70 years and olderHealthy volunteers can take part
Conditions the study is for
Mobility Limitation
How many people
130 participants
Where
1 siteUnited States
Study dates
17 Jan 2017to 6 Apr 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: 60 patients being seen in the post operative assessment clinic will be asked to complete the Mobility Assessment Tool. A family member/caregiver of each patient will be asked to complete the test on the behalf of the patient at the same visit and asked to complete again 1-14 days later.

Who may be able to join

  • Patients aged 70 years and older being seen at the PAC;
  • Patients who have caregiver or family who meet the criteria for surrogate as above;
  • Patients scheduled for elective surgical procedures.

Who cannot join

  • Patients who have a language barrier which will prohibit them from understanding the questionnaire and directions connected to the use of the MAT-sf;
  • Patients who are not able to sign their own surgical consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157

Other trials in United States

About this study

The purpose of this research study is to find out if mobility (the ability to move around) can be reliably assessed by having the family or care giver caregiver take a video based test for the patient. If this study shows that mobility can be assessed by family or caregiver, this information can be used in situations where mobility cannot be measured directly in patients. A total of 60 patients and 60 family/caregivers at Wake Forest Baptist Medical Center will take part in this study. Patients physical function will be assessed using a test that uses short movie clips to assess mobility. Patients will be asked to watch ten short (~10 seconds each) movie clips that describe various tasks such as climbing up hills or walking and estimate if they can perform the tasks. The familymember/caregiver will be also asked to answer the questions on behalf of the patient. The family member/caregiver will be asked to return to take the same test in the next 1-14 days. The patient will be in the study for one day. There is no intervention, this is observational.

Read the detailed description

According to the U.S. Census Bureau projections, the number of persons 65 years of age or older will increase from roughly 40 million in the year 2010, to 88.5 million in 2050, a net increase of 121%. During this same time period, the number of persons 85 years of age or older will increase by 227%; accounting for nearly 5% of the U.S. population. Mobility and functional status are important predictors of outcomes in this rapidly growing elderly population. It has shown that walking speed and physical function, measured by Short Physical Performance Battery (SPPB) are predictors of mortality in community-dwelling older men and women. It was also reported that gait speed predicts incident disability in community dwelling elderly subjects. In our prior study, we have demonstrated that, mobility, assessed using an animated video clip based assessment tool, Mobility Assessment Tool-short form (MAT-sf) predicts postoperative complications, length of stay and nursing home placement in elderly patients (>69) who were undergoing elective surgery that requires overnight hospitalization and more clinical practices use physical function and mobility as a tool to predict outcomes.

However, these assessments are not always readily available, especially in clinical situations when acute illnesses or injuries occurred without any chance to assess the baseline status, such as acute myocardial infract, rapidly progressing sepsis or catastrophic trauma. In these cases, patients are often sedated, intubated, have altered mental status, or too unstable to perform even non-invasive testing. Although some clinicians or researchers feel that surrogate can accurately assess the patients' baseline physical function and mobility status, it was never been tested.

The investigators hypothesize that mobility assessment done on surrogates, using MAT-sf will have high compatibility with the assessment done on elderly patients. Surrogates are defined as a person who spends >2 hours a day or 8 hours a week with the patient and accompany the patient to most of their medical appointments. The investigators will test the hypothesis at the Preoperative Assessment Clinic since this clinic sees high volume of elderly patients and patients at this clinic tend to have their caregiver with them during the appointments.

Investigators will enroll 20 patients in poor mobility group (MAT-sf < 51.38 in men and <45.61 in women), 20 patients into the mid-mobility group (51.38< MAT-sf≤65.5 in men and 45.61≤MAT-sf<54.02) and 20 patients into the high mobility group (MAT-sf>65.5 in men and MAT-sf>54.02 in women) for a total of 60 patients and one surrogate per patient for a total of 120 unique participants.

To assess mobility, participants will be instructed on the use of the Mobility Assessment Tool-short form (MAT-sf). The MAT-sf is a 10-item computer based assessment of mobility using animated video clips. The 10 items in the MAT-sf cover a broad range of functioning. The items include walking on level ground, a slow jog, walking outdoors on uneven terrain, walking up a ramp with and without using a handrail, stepping over hurdles, ascending and descending stairs with and without the use of a handrail, and climbing stairs while carrying bags. The items were previously selected based on individual response and information curves derived from Item Response Theory. Each item is accompanied by an animated video clip together with the responses for that question (number of minutes, number of times, yes/no). The test will be performed on an I-PAD and scores will be saved to an exportable file. The time required to do the test with instructions from the examiner is expected to be no longer than 5 minutes. While the patient is completing the MAT-sf assessment, the surrogate will be directed to a separate room to complete MAT-sf for the patient ("Do you think Mr ** can climb up this hill?) , so there is no interaction between the patient and the surrogate during the assessment. Investigators will measure the compatibility between patients-surrogates mobility using MAT-sf and will also assess the stability of surrogate MAT-sf.

Keywords
mobility assessment tool
Medical subject headings
Mobility Limitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03032341
Study groupRoleWhat they receive
Patient group20 patient in poor mobility group (MAT-sf < 51.38 in men and <45.61 in women), mid-mobility group (51.38< MAT-sf≤65.5 in men and 45.61≤MAT-sf<54.02) and high mobility group (MAT-sf>65.5 in men and MAT-sf>54.02 in women) for a total of 60 patients.
Surrogate groupA family member/caregiver that attends visits with the patient and will be asked to answer the Mobility Assessment Test questionnaire on behalf of the patient at the initial visit and the follow up visit 1-14 days later.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in MAT-sf score between patients and surrogates

    Investigators will measure the compatibility between patients-surrogates mobility using MAT-sf.

    Measured: 1-14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2017 (estimated)
  2. Study start17 Jan 2017
  3. Primary completion6 Apr 2017
  4. Study completion6 Apr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03032341
Sponsor's protocol ID
IRB00040417
Acronym
MAT
Status last verified
Dec 2017
First submitted
18 Jan 2017
Last updated
19 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mobility Limitation, run by Wake Forest University Health Sciences at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in MAT-sf score between patients and surrogates (time frame: 1-14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in